Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions Results of the OPTIMIZE Randomized Study

Overview

cited authors

Kereiakes, Dean J.; Feldman, Robert L.; Ijsselmuiden, A. J. J.; Saito, Shigeru; Amoroso, Giovanni; Zidar, James P.; Wong, S. Chiu; Stella, Pieter; Yakubov, Steven; Lasala, John; Cohen, David J.; Doros, Gheorghe; Cutlip, Donald E.; Rao, Sunil, V

authors

Feldman, Robert L., MD, FACC, FSCAI

Publication Date

September 1, 2021

webpage

Web of Science

published in

CIRCULATION-CARDIOVASCULAR INTERVENTIONS Journal

Research

keywords

drug-eluting stent
everolimus
percutaneous coronary intervention
polymer
sirolimus

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.